Immucell (ICCC) Assets (2010 - 2026)
Immucell's (ICCC) quarterly Assets came in at $42.5 million in Q4 2025, down 5.69% YoY from $45.1 million in Q4 2024, and down 6.99% on a QoQ basis from $45.7 million in Q3 2025.
Immucell (ICCC) Assets (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Assets data on file, last reported at $42.5 million in Q4 2025.
- Quarterly Assets fell 5.69% year-over-year to $42.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.5 million (down 5.69% YoY) and the FY2025 annual result came in at $42.5 million, down 5.69% from the prior year.
- Assets retreated to $42.5 million in Q4 2025, from $45.7 million in the prior quarter.
- In the past five years, Assets ranged from a high of $46.7 million in Q2 2025 to a low of $39.6 million in Q1 2021.
- A 5-year average of $44.3 million and a median of $44.5 million in 2021 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets gained 17.86% — and 2023, when it retreated 7.66%.
- Tracing ICCC's Assets over 5 years: stood at $44.5 million in 2021, then advanced by 0.89% to $44.9 million in 2022, then fell by 2.35% to $43.8 million in 2023, then advanced by 2.95% to $45.1 million in 2024, then dropped by 5.69% to $42.5 million in 2025.
- The last three Assets figures came in at $42.5 million (Q4 2025), $45.7 million (Q3 2025), and $46.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 46.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.63 Mn |
| Dec 31, 2025 | 42.53 Mn |
| Sep 30, 2025 | 45.73 Mn |
| Jun 30, 2025 | 46.72 Mn |
| Mar 31, 2025 | 45.62 Mn |
| Dec 31, 2024 | 45.10 Mn |
| Sep 30, 2024 | 44.45 Mn |
| Jun 30, 2024 | 41.86 Mn |
| Mar 31, 2024 | 43.05 Mn |
| Dec 31, 2023 | 43.81 Mn |
| Sep 30, 2023 | 44.55 Mn |
| Jun 30, 2023 | 44.01 Mn |
| Mar 31, 2023 | 43.12 Mn |
| Dec 31, 2022 | 44.86 Mn |
| Sep 30, 2022 | 46.40 Mn |
| Jun 30, 2022 | 45.98 Mn |
| Mar 31, 2022 | 46.70 Mn |
| Dec 31, 2021 | 44.47 Mn |
| Sep 30, 2021 | 44.23 Mn |
| Jun 30, 2021 | 43.73 Mn |